Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
The TNM (Tumor size, Node (lymph) & Metastases) classification is not used for brain tumors for:
A. Most patients with CNS tumors develop metastatic disease
Most patients with CNS tumors do not develop metastatic disease. Central nervous system (CNS) tumors, including brain tumors, typically do not metastasize outside the CNS. Instead, they grow and exert pressure on adjacent brain structures, leading to neurological symptoms.
B. Brain tumors are more deadly
While brain tumors can be very deadly, the TNM classification system is not avoided due to the lethality of the tumors. The main reason for not using the TNM system is because the classification criteria do not align well with the unique aspects of brain tumors.
C. Tumor size is less relevant than the location and histology
Tumor size is less relevant than the location and histology for brain tumors. The location of the tumor within the brain and its histological characteristics (e.g., type, grade, and molecular features) are more critical for prognosis and treatment planning. Brain tumors can cause significant clinical issues even when small, depending on their location.
D. Brain tumors have poor prognosis
Brain tumors can have a poor prognosis, but this is not the reason the TNM classification is not used. The classification system's limitation is primarily due to the fact that brain tumors' behavior and treatment considerations depend more on their location and histological features than on tumor size, nodal involvement, and metastasis, which are the focus of the TNM system.
This question is an excerpt from Nurse Dive's nursing test bank - Ati pathophisiology proctored exam. Take the full exam now
Full Explanation
Choice A reason: Most patients with CNS tumors do not develop metastatic disease. Central nervous system (CNS) tumors, including brain tumors, typically do not metastasize outside the CNS. Instead, they grow and exert pressure on adjacent brain structures, leading to neurological symptoms.
Choice B reason: While brain tumors can be very deadly, the TNM classification system is not avoided due to the lethality of the tumors. The main reason for not using the TNM system is because the classification criteria do not align well with the unique aspects of brain tumors.
Choice C reason: Tumor size is less relevant than the location and histology for brain tumors. The location of the tumor within the brain and its histological characteristics (e.g., type, grade, and molecular features) are more critical for prognosis and treatment planning. Brain tumors can cause significant clinical issues even when small, depending on their location.
Choice D reason: Brain tumors can have a poor prognosis, but this is not the reason the TNM classification is not used. The classification system's limitation is primarily due to the fact that brain tumors' behavior and treatment considerations depend more on their location and histological features than on tumor size, nodal involvement, and metastasis, which are the focus of the TNM system.
Similar Questions
The release of insulin is caused by:
A. Increased lipid breakdown
Increased lipid breakdown does not directly cause the release of insulin. Insulin is a hormone that facilitates glucose uptake by cells and helps regulate blood sugar levels. Lipid metabolism is primarily regulated by other mechanisms and hormones, such as glucagon and epinephrine.
B. Decreased blood glucose level
Decreased blood glucose level would not stimulate insulin release. In fact, low blood glucose levels would signal the pancreas to reduce insulin secretion. Instead, glucagon would be released to increase blood glucose levels by stimulating the conversion of glycogen to glucose in the liver.
C. Increased protein breakdown
Increased protein breakdown does not directly trigger the release of insulin. Protein metabolism involves amino acids and other metabolic pathways, but insulin release is primarily regulated by blood glucose levels.
D. Increased blood glucose level
The release of insulin is caused by increased blood glucose levels. When blood glucose levels rise, such as after eating a meal, the beta cells in the pancreas secrete insulin to help cells absorb glucose from the bloodstream, thereby lowering blood glucose levels and maintaining homeostasis.
Full Explanation
Choice A reason: Increased lipid breakdown does not directly cause the release of insulin. Insulin is a hormone that facilitates glucose uptake by cells and helps regulate blood sugar levels. Lipid metabolism is primarily regulated by other mechanisms and hormones, such as glucagon and epinephrine.
Choice B reason: Decreased blood glucose level would not stimulate insulin release. In fact, low blood glucose levels would signal the pancreas to reduce insulin secretion. Instead, glucagon would be released to increase blood glucose levels by stimulating the conversion of glycogen to glucose in the liver.
Choice C reason: Increased protein breakdown does not directly trigger the release of insulin. Protein metabolism involves amino acids and other metabolic pathways, but insulin release is primarily regulated by blood glucose levels.
Choice D reason: The release of insulin is caused by increased blood glucose levels. When blood glucose levels rise, such as after eating a meal, the beta cells in the pancreas secrete insulin to help cells absorb glucose from the bloodstream, thereby lowering blood glucose levels and maintaining homeostasis.
Hyperglycemic Hyperosmolar Nonketoic (HHNK) is an acute complication of:
A. Gestation Diabetes
Gestational diabetes is a form of diabetes that occurs during pregnancy and typically resolves after childbirth. It is not typically associated with Hyperglycemic Hyperosmolar Nonketoic (HHNK) Syndrome, which is a specific complication of type 2 diabetes.
B. Type 2 Diabetes
Type 2 diabetes is characterized by insulin resistance and high blood glucose levels. HHNK is a serious acute complication of type 2 diabetes, occurring when blood glucose levels become extremely high, leading to severe dehydration and hyperosmolarity without significant ketoacidosis. This condition requires immediate medical attention.
C. Type 1 & Type 2 Diabetes
While both type 1 and type 2 diabetes involve issues with blood glucose regulation, HHNK is specifically associated with type 2 diabetes. Type 1 diabetes complications more commonly include Diabetic Ketoacidosis (DKA), rather than HHNK.
D. Type 1 Diabetes
Type 1 diabetes is characterized by the body's inability to produce insulin, leading to high blood glucose levels. However, the primary acute complication of type 1 diabetes is Diabetic Ketoacidosis (DKA), not HHNK. HHNK is distinct to type 2 diabetes, where insulin resistance leads to extremely high blood glucose levels and severe dehydration.
Full Explanation
Choice A reason: Gestational diabetes is a form of diabetes that occurs during pregnancy and typically resolves after childbirth. It is not typically associated with Hyperglycemic Hyperosmolar Nonketoic (HHNK) Syndrome, which is a specific complication of type 2 diabetes.
Choice B reason: Type 2 diabetes is characterized by insulin resistance and high blood glucose levels. HHNK is a serious acute complication of type 2 diabetes, occurring when blood glucose levels become extremely high, leading to severe dehydration and hyperosmolarity without significant ketoacidosis. This condition requires immediate medical attention.
Choice C reason: While both type 1 and type 2 diabetes involve issues with blood glucose regulation, HHNK is specifically associated with type 2 diabetes. Type 1 diabetes complications more commonly include Diabetic Ketoacidosis (DKA), rather than HHNK.
Choice D reason: Type 1 diabetes is characterized by the body's inability to produce insulin, leading to high blood glucose levels. However, the primary acute complication of type 1 diabetes is Diabetic Ketoacidosis (DKA), not HHNK. HHNK is distinct to type 2 diabetes, where insulin resistance leads to extremely high blood glucose levels and severe dehydration.
What would be the treatment of choice for hypovolemia due to hemorrhage?
A. Increase red meat in diet
Increasing red meat in the diet is not an appropriate treatment for hypovolemia due to hemorrhage. While red meat contains iron, which is important for blood production, it does not address the immediate need to replace lost blood volume.
B. Infuse D5NS @ 75 ml/hr X 10 hours
Infusing D5NS (5% Dextrose in Normal Saline) at 75 ml/hr for 10 hours may help replenish fluid volume, but it does not provide the necessary components to replace lost blood cells and clotting factors. This option is not sufficient for severe hemorrhage.
C. Replacement of volume with blood products
Replacement of volume with blood products is the treatment of choice for hypovolemia due to hemorrhage. Blood transfusions provide the necessary red blood cells, plasma, and clotting factors to restore blood volume and improve oxygen delivery to organs. This is crucial in managing severe blood loss and preventing complications such as hypovolemic shock.
D. Increase H2O to 400 ml/4 hr X 24 hours
Increasing H2O (water) intake to 400 ml/4 hr for 24 hours is not an appropriate treatment for hypovolemia due to hemorrhage. While hydration is important, it does not address the immediate need to replace lost blood volume and components.
Full Explanation
Choice A reason: Increasing red meat in the diet is not an appropriate treatment for hypovolemia due to hemorrhage. While red meat contains iron, which is important for blood production, it does not address the immediate need to replace lost blood volume.
Choice B reason: Infusing D5NS (5% Dextrose in Normal Saline) at 75 ml/hr for 10 hours may help replenish fluid volume, but it does not provide the necessary components to replace lost blood cells and clotting factors. This option is not sufficient for severe hemorrhage.
Choice C reason: Replacement of volume with blood products is the treatment of choice for hypovolemia due to hemorrhage. Blood transfusions provide the necessary red blood cells, plasma, and clotting factors to restore blood volume and improve oxygen delivery to organs. This is crucial in managing severe blood loss and preventing complications such as hypovolemic shock.
Choice D reason: Increasing H2O (water) intake to 400 ml/4 hr for 24 hours is not an appropriate treatment for hypovolemia due to hemorrhage. While hydration is important, it does not address the immediate need to replace lost blood volume and components.